This article provides a comprehensive guide for researchers and pharmaceutical scientists on critically distinguishing between nanoparticle core, hydrodynamic, and effective diameters.
This article provides a comprehensive guide for researchers and pharmaceutical scientists on critically distinguishing between nanoparticle core, hydrodynamic, and effective diameters. We cover foundational concepts, standard and advanced measurement methodologies (DLS, NTA, TEM, SEC), common experimental challenges and optimization strategies, and validation approaches for correlating size data with biological performance. This resource aims to empower accurate characterization essential for predicting nanomedicine biodistribution, stability, and efficacy.
This support center addresses common experimental issues in differentiating nanoparticle core, hydrodynamic, and effective diameters.
Q1: My Dynamic Light Scattering (DLS) results show a much larger diameter than my Transmission Electron Microscopy (TEM) data. Which is correct, and why do they differ?
Q2: When should I use Nanoparticle Tracking Analysis (NTA) vs. DLS for hydrodynamic size?
Q3: My "effective diameter" from Phase Analysis Light Scattering (PALS) for zeta potential seems inconsistent with my DLS hydrodynamic diameter. Is this an error?
Q4: How do I accurately measure the core diameter of a polymer nanoparticle if TEM causes shrinkage?
Table 1: Comparison of Key Diameter Measurement Techniques
| Technique | Measures (Primary Output) | Typical Size Range | Sample State | Key Output Parameter | Polydisperse Sample Suitability |
|---|---|---|---|---|---|
| TEM / SEM | Core Diameter | 1 nm - 10 µm | Dry, Vacuum | Number-average size, Image | Moderate (requires many particles) |
| DLS | Hydrodynamic Diameter | 0.3 nm - 10 µm | Solution, Native | Intensity-weighted Z-average, PDI | Poor (biased towards larger particles) |
| NTA | Hydrodynamic Diameter | 30 nm - 1 µm | Solution, Native | Particle concentration, Size distribution | Good (visual validation) |
| SAXS | Core Radius, Shell Thickness | 1 nm - 100 nm | Solution, Native | Core size, Shell density/profile | Moderate (models required) |
| PALS / ELS | Effective (Electrokinetic) Diameter | 3 nm - 10 µm | Solution, Native | Zeta Potential, Mobility | Poor (assumes monodispersity) |
Protocol 1: Determining Core vs. Hydrodynamic Diameter via TEM and DLS
(DLS / TEM) indicates coating thickness and aggregation state. A ratio >1.3 suggests a significant coating or poor dispersion.Protocol 2: Measuring Effective Diameter and Zeta Potential via Phase Analysis Light Scattering (PALS)
f(κa) = 1.5 (Smoluchowski).
Title: Nanoparticle Diameter Measurement Decision Workflow
Title: The Triad of Nanoparticle Diameters Visualized
Table 2: Essential Materials for Nanoparticle Sizing Experiments
| Item | Function & Rationale |
|---|---|
| Anodisc Syringe Filters (0.02-0.2 µm) | Gold-standard for filtering nanoparticle suspensions prior to DLS/NTA. Minimal sample adsorption and particle shedding. |
| Dialysis Membranes (MWCO appropriate) | For exchanging solvent or buffer to control ionic strength prior to zeta potential measurements, crucial for accurate effective diameter calculation. |
| Carbon-coated TEM Grids | Provide a clean, conductive, and low-background substrate for high-resolution TEM imaging of core size. |
| Standard Latex/Nanosphere Size Standards | Essential for daily calibration and validation of DLS, NTA, and zeta potential instruments. |
| Potassium Chloride (1 mM Solution) | Recommended electrolyte for standardizing zeta potential measurements due to its well-defined ionic mobility. |
| HPLC-grade Solvents (Water, Toluene, etc.) | Minimize particulate contamination and fluorescent impurities that interfere with light scattering techniques. |
| Stable Reference Nanoparticle Sample | A well-characterized, in-lab standard (e.g., 100 nm PS-NH2) for routine quality control of measurement protocols. |
FAQ 1: Our DLS measurements consistently show a larger hydrodynamic diameter than the TEM core diameter. Is this normal, and how do I interpret the discrepancy? Answer: Yes, this is expected. Dynamic Light Scattering (DLS) measures the hydrodynamic diameter (Dh), which includes the core, coating (e.g., PEG), and the solvation shell. Transmission Electron Microscopy (TEM) measures the core diameter (Dc) of the dry, static particle. A significant discrepancy (>10-20 nm for PEGylated particles) often indicates a thick stabilizing layer or aggregation. First, confirm sample preparation: for DLS, ensure the sample is filtered (0.22 µm) and free of dust. For TEM, check for drying artifacts that may shrink the coating.
FAQ 2: Our nanoparticle batch shows a high PDI (>0.3) in DLS. How does this affect biodistribution studies, and how can we improve monodispersity? Answer: A high Polydispersity Index (PDI) indicates a heterogeneous size population, which can cause variable biodistribution and pharmacokinetics. Larger aggregates may be sequestered by the liver and spleen, while smaller particles circulate longer. To improve monodispersity:
FAQ 3: The nanoparticle size and PDI change after incubation in biological media (e.g., serum). What is causing this instability? Answer: This indicates protein corona formation and potential aggregation. Proteins adsorb onto the nanoparticle surface, increasing the measured hydrodynamic diameter and potentially destabilizing the formulation. To troubleshoot:
FAQ 4: How do I accurately determine the core diameter for particles with a thick polymer shell? Answer: For thick shells, TEM may underestimate the core if contrast is poor. Use a combination:
FAQ 5: How does the hydrodynamic diameter directly influence pharmacokinetic (PK) parameters? Answer: Hydrodynamic diameter is a primary determinant of renal clearance and hepatic filtration. See the quantitative summary below.
Table 1: Nanoparticle Size vs. Pharmacokinetic and Biodistribution Parameters
| Hydrodynamic Diameter (Dh) Range | Primary Clearance Pathway | Typical Circulation Half-life (in mice) | Predominant Organ Accumulation |
|---|---|---|---|
| < 6 nm | Renal (kidney) filtration | Minutes to < 1 hour | Kidneys, Bladder |
| 6 - 8 nm | Transition zone | ~1-2 hours | Renal + Hepatic |
| 10 - 150 nm | Mononuclear Phagocyte System | Hours to days | Liver, Spleen |
| > 200 nm | Mechanical filtration | Minutes to hours | Lungs, Spleen (capillaries) |
Table 2: Common Techniques for Core vs. Hydrodynamic Diameter Determination
| Technique | What it Measures | Sample State | Key Output | Limitation for Distinction |
|---|---|---|---|---|
| TEM / SEM | Core Diameter (Dc) | Dry, Vacuum | 2D projection image, size histogram | Misses soft coating, hydration shell |
| DLS | Hydrodynamic Diameter (Dh) | Solution, Native | Intensity-weighted size, PDI | Sensitive to aggregates, poor for polydisperse samples |
| SAXS | Core & Shell (model-dependent) | Solution | Mathematical model of structure | Requires fitting models, complex analysis |
| NTA | Hydrodynamic Diameter (Dh) | Solution, Native | Particle-by-particle size, concentration | Lower resolution than DLS, sensitive to sample prep |
Protocol 1: Correlative Analysis of Core and Hydrodynamic Diameter Objective: To accurately determine both Dc and Dh for a single nanoparticle batch. Materials: Nanoparticle suspension, TEM grid (carbon-coated), filter (0.22 µm), DLS instrument, TEM. Method:
Protocol 2: Assessing Stability in Biological Media Objective: To monitor changes in hydrodynamic diameter and PDI upon exposure to serum. Materials: Nanoparticle suspension, fetal bovine serum (FBS), PBS, DLS instrument, incubator. Method:
Title: Hydrodynamic vs Core Diameter Composition
Title: Hydrodynamic Diameter Dictates In Vivo Fate
| Item / Reagent | Primary Function in Characterization |
|---|---|
| Dynamic Light Scattering (DLS) Instrument | Measures hydrodynamic diameter (Dh) and PDI in native solution state. |
| Transmission Electron Microscope (TEM) | Provides high-resolution 2D images for core diameter (Dc) analysis. |
| Zeta Potential Analyzer | Measures surface charge, critical for predicting colloidal stability. |
| Size-Exclusion Chromatography (SEC) Columns | Purifies nanoparticles by size, removes aggregates/unbound polymer. |
| Tangential Flow Filtration (TFF) System | Concentrates and diafilters nanoparticle suspensions at scale. |
| Phosphotungstic Acid (PTA, 2% w/v) | Negative stain for TEM to visualize polymer shells or coatings. |
| Anotop 0.22 µm Syringe Filters (e.g., PTFE) | Filters samples for DLS to remove dust and large aggregates. |
| Carbon-Coated TEM Grids (200 mesh) | Standard substrate for preparing nanoparticle samples for TEM imaging. |
FAQ 1: My DLS measurements consistently show a larger hydrodynamic diameter than expected from TEM core size. What could be the cause?
Answer: This is a fundamental observation when comparing core vs. hydrodynamic diameter. The increase is primarily due to the particle's "atmosphere." The hydrodynamic diameter (Dh) measured by DLS includes the core, the solvation shell (bound water/liquid), and any adsorbed molecules (corona). A significant discrepancy suggests:
Troubleshooting Steps:
FAQ 2: How can I experimentally distinguish the contribution of the solvation shell from the protein corona to the total hydrodynamic diameter increase?
Answer: This requires a combination of techniques that probe different layers of the particle atmosphere.
Experimental Protocol: Differential Centrifugal Sedimentation (DCS) & DLS Comparison
FAQ 3: My nanoparticle formulation shows batch-to-batch variability in hydrodynamic diameter in serum-containing media. How can I standardize corona formation?
Answer: Variability often stems from inconsistent nanoparticle surface chemistry or serum incubation conditions.
Troubleshooting Guide:
Table 1: Typical Size Increments from Particle Atmosphere Layers (Silica Nanoparticle Example, ~50 nm core)
| Layer / Component | Approximate Thickness (nm) | Contributing Technique to Measure | Key Influencing Factor |
|---|---|---|---|
| Core Diameter | 50.0 (reference) | TEM, SEM | Synthesis conditions |
| Solvation Shell | 0.5 - 3.0 | DLS (in buffer vs. organic solvent) | Surface hydrophilicity, solvent |
| Hard Protein Corona | 3.0 - 15.0 | DCS, SEC-DLS, UV-Vis depletion assay | Surface charge, serum type, time |
| Soft Protein Corona | 5.0 - 20.0 (dynamic) | NMR, Fluorescence correlation spectroscopy | Incubation conditions, affinity |
| Total Hydrodynamic Diameter (Dh) | 59.0 - 90.0 | Dynamic Light Scattering (DLS) | All of the above |
Table 2: Comparison of Techniques for Core vs. Hydrodynamic Diameter Determination
| Technique | Measures | Sample Environment | Key Limitation for Atmosphere Study |
|---|---|---|---|
| TEM / SEM | Core Diameter | Dry, Vacuum | Does not see solvation or corona |
| Dynamic Light Scattering (DLS) | Hydrodynamic Diameter (Dh) | Liquid, native state | Cannot deconvolute individual layers |
| Differential Centrifugal Sedimentation (DCS) | Size distribution via sedimentation | Liquid, dense medium | Requires known particle density |
| Asymmetric Flow Field-Flow Fractionation (AF4) | Separates particles by hydrodynamic size | Liquid, can couple to detectors | Can isolate fractions for further analysis |
| Nuclear Magnetic Resonance (NMR) | Solvation shell, corona dynamics | Liquid, native state | Requires specialized analysis (e.g., relaxation) |
Protocol: Isolating and Analyzing the Hard Protein Corona via Ultracentrifugation & SDS-PAGE Objective: To isolate the hard protein corona for identification and quantification. Materials: Nanoparticle dispersion, complete cell culture media (e.g., DMEM + 10% FBS), ultracentrifuge, PBS.
Protocol: Determining Solvation Shell Contribution via Solvent-Viscosity DLS Series Objective: To approximate the solvation shell thickness by varying solvent viscosity. Materials: Nanoparticles, organic solvent (e.g., toluene), glycerol, DLS instrument, viscometer.
Diagram 1: Nanoparticle Atmosphere Layers
Diagram 2: Experimental Workflow for Core vs. Hydrodynamic Diameter Analysis
| Item | Function & Relevance to Atmosphere Studies |
|---|---|
| Size Exclusion Chromatography (SEC) Columns (e.g., Sepharose CL-4B) | Separates nanoparticle-corona complexes from free, unbound proteins in solution to isolate the complex for analysis. |
| Ultracentrifugation Tubes (Polycarbonate) | Used for high-speed pelleting of nanoparticles to isolate the hard corona or to clean samples before DLS. |
| Dynamic Light Scattering (DLS) Instrument | The primary tool for measuring the intensity-weighted hydrodynamic diameter (Z-average) of particles in suspension. |
| Differential Centrifugal Sedimentation (DCS) Instrument | Provides high-resolution size distributions based on sedimentation rate, sensitive to density changes from corona adsorption. |
| Asymmetric Flow Field-Flow Fractionation (AF4) System | Gently separates polydisperse or aggregated samples by hydrodynamic size prior to DLS or MS detection. |
| Capillary Viscometer | Accurately measures the absolute viscosity of complex biological fluids required for correct Dh calculation in DLS. |
| SDS-PAGE Gel Electrophoresis System | Standard method for separating, visualizing, and roughly quantifying proteins eluted from the hard corona. |
| Mass Spectrometry (LC-MS/MS) | Identifies the specific protein components of the isolated corona, enabling proteomic analysis. |
| Zeta Potential Analyzer | Measures surface charge (zeta potential), which is crucial for predicting corona composition and colloidal stability. |
Q1: My DLS measurement shows a consistently larger particle size than my TEM analysis. Which one is the "correct" diameter, and why does this discrepancy happen?
A: Both are correct but measure different properties. Dynamic Light Scattering (DLS) reports the hydrodynamic diameter, which includes the core, any surface coating, and the solvation shell (adsorbed solvent/ions). Transmission Electron Microscopy (TEM) measures the core diameter (or dry state particle size) from a 2D projection. The discrepancy is expected and is fundamentally dictated by material composition and surface chemistry. A thick polymer coating or a charged surface creating a large ionic atmosphere will significantly increase the DLS size relative to TEM.
Q2: How does nanoparticle composition affect the relationship between core and hydrodynamic diameter?
A: Composition directly determines the surface energy and required stabilization strategy, which dictates the type and thickness of the surface layer. This layer is included in the hydrodynamic diameter.
Q3: I am synthesizing PEGylated gold nanoparticles. My UV-Vis shows a peak at 520 nm, but my DLS size is highly polydisperse. What could be wrong with my surface functionalization?
A: This indicates a problem with the surface chemistry step, not the core synthesis. A sharp plasmon peak suggests a uniform gold core. Polydisperse DLS indicates aggregation during PEGylation. Common issues:
Q4: When should I use DLS vs. TEM vs. NTA for size analysis in drug delivery development?
A: The choice depends on the property you need to characterize for your regulatory filing or functional understanding.
| Technique | Measures | Key Influence of Composition/Surface | Best For | Typical Output |
|---|---|---|---|---|
| TEM | Core/ Dry Diameter | Core material electron density, staining requirement. | Visualizing core size, shape, and crystallinity. | Number-average diameter (e.g., 15.2 ± 2.1 nm) |
| DLS | Hydrodynamic Diameter | Thickness of coating/solvation layer, surface charge (via intensity weighting). | Assessing stability in formulation buffer, detecting aggregates. | Z-average (e.g., 42.8 nm), PDI (e.g., 0.08) |
| NTA | Hydrodynamic Diameter (particle-by-particle) | Optical properties of core & coating affect scattering/fluorescence. | Analyzing polydisperse or complex mixtures (e.g., with vesicles). | Concentration & size distribution profile (e.g., mode = 38 nm) |
Q5: My nanoparticle formulation appears stable by DLS in water but aggregates immediately in cell culture media. How does surface composition explain this?
A: This is a classic "protein corona" effect. Your surface chemistry (likely charged or with certain functional groups) is optimized for stability in pure water. In biological media, proteins rapidly adsorb onto the nanoparticle surface, forming a dynamic corona. The new, protein-coated surface may have different electrostatic and steric properties, leading to aggregation. The solution is to engineer a surface composition (e.g., dense PEG brush) that minimizes non-specific protein adsorption.
Objective: To systematically determine the thickness of the surface coating (PEG layer) on gold nanoparticles (AuNPs).
Materials: See "The Scientist's Toolkit" below.
Method:
Objective: To evaluate the change in hydrodynamic diameter due to protein corona formation.
Method:
| Item | Function & Relevance to Size Analysis |
|---|---|
| Citrate-stabilized Gold Nanoparticles | Standard model system for studying surface functionalization. Core size easily tuned (10-100 nm) and characterized by UV-Vis/TEM. |
| Methoxy-PEG-Thiol (various MWs) | The thiol group chemisorbs to gold/quantum dots. The PEG chain provides a steric barrier, directly increasing hydrodynamic diameter proportionally to its molecular weight. |
| Ultrafiltration Centrifugal Devices (e.g., 100 kDa MWCO) | Critical for purifying functionalized nanoparticles and removing unbound ligands/surfactants that can interfere with DLS measurements. |
| Particle Size Standards (e.g., NIST-traceable latex beads) | Essential for calibrating and validating DLS and NTA instruments to ensure accurate hydrodynamic diameter reporting. |
| Filtered Buffers (0.22 µm or 0.1 µm filtered) | Dust and aggregates in buffers are a primary source of noise and error in DLS. All solvents for DLS must be rigorously filtered. |
| Carbon-coated TEM Grids | Standard substrate for high-resolution imaging of nanoparticle cores. Hydrophilic treatment may be needed for some samples. |
| Dynamic Light Scattering (DLS) Instrument | Measures fluctuations in scattered light to determine the diffusion coefficient and calculate the hydrodynamic diameter. |
| Transmission Electron Microscope (TEM) | Provides direct, high-resolution images of the nanoparticle core for measuring core size, shape, and crystallinity. |
This support center addresses common issues in nanoparticle sizing experiments, framed within a thesis research context on determining core vs. hydrodynamic diameter.
Q1: My Dynamic Light Scattering (DLS) measurement shows a high polydispersity index (PDI > 0.3). What are the likely causes and solutions? A: A high PDI indicates a non-uniform particle population. Common causes are:
Q2: When comparing TEM (core) and DLS (hydrodynamic) diameters, my DLS size is consistently 10-30 nm larger. Is this an error? A: No, this is expected and core to your thesis. DLS measures the hydrodynamic diameter, which includes the core, coating, and the solvent layer moving with the particle. TEM measures the core diameter of dried, static particles. The difference can be attributed to the ligand/surface coating thickness and solvation effects. This discrepancy is a key finding, not a fault.
Q3: My Nanoparticle Tracking Analysis (NTA) concentration results are significantly lower than expected. How can I troubleshoot this? A: NTA is sensitive to instrument settings and sample properties.
Q4: For regulatory submissions (e.g., to FDA/EMA), what are the key sizing methods and data presentation requirements? A: Regulatory guidelines (e.g., FDA guidance for liposomes, EMA for block copolymer micelles) emphasize method robustness and data integrity.
| Standard Organization | Standard Code/Name | Focus Area | Key Prescribed/Recommended Methods |
|---|---|---|---|
| International Organization for Standardization (ISO) | ISO 22412:2017 | Dynamic Light Scattering (DLS) | Defines measurement, reporting, and data interpretation for DLS. Mandates reporting of Z-average, PDI, and distribution. |
| ASTM International | E2834-12 (2022) | Guide for NTA | Provides standard guide for measurement of particle size distribution by Nanoparticle Tracking Analysis. |
| US Pharmacopeia (USP) | <729> | Globule Size Distribution in Lipid Injectables | Specifies measurement of fat emulsion/liposome droplet size by light scattering (DLS) or light obscuration. Sets limits for large-diameter particles. |
| FDA & EMA | Various Product-Specific Guidances | Nanomedicine & Complex Drug Products | Recommend DLS as primary sizing method. Require orthogonal method (e.g., TEM, AFM) for core size. Emphasize monitoring size stability. |
Objective: To characterize a batch of PEGylated gold nanoparticles (AuNP-PEG) using orthogonal techniques to determine both core and hydrodynamic diameter.
Materials:
Procedure:
Part A: Hydrodynamic Diameter by DLS
Part B: Core Diameter by TEM
Diagram Title: Core vs Hydrodynamic Diameter Measurement Principles
Diagram Title: Troubleshooting High PDI in DLS Measurements
| Item | Function in Core/Hydrodynamic Sizing Experiments |
|---|---|
| 0.1 µm Syringe Filter (PES or PVDF) | Critical for filtering buffers and samples to remove dust/aggregates before DLS/NTA, reducing background noise. |
| Particle-Size Standard Kits (e.g., 60nm Au, 100nm PS) | Used to validate and calibrate DLS, NTA, and TEM instruments for accuracy. |
| Formvar/Carbon TEM Grids | Standard substrates for depositing nanoparticles for core size imaging by TEM. |
| Phosphotungstic Acid (PTA) / Uranyl Acetate | Negative stains used to enhance contrast of soft, biological nanoparticles (e.g., liposomes, exosomes) in TEM. |
| Particle-Free Water/Buffer | Certified to contain minimal particulate background, essential for preparing dilution blanks and controls. |
| Disposable, Low-Binding Microcentrifuge Tubes & Pipette Tips | Minimizes particle loss due to adsorption onto container walls, crucial for accurate concentration measurements. |
| Zeta Potential Reference Standard (e.g., -50mV ± 5) | Used to validate the performance of the electrophoretic mobility module in a DLS/Zetasizer instrument. |
This support center addresses common issues in determining nanoparticle hydrodynamic diameter (Dh) using Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA). This data is critical within the broader research context of differentiating core diameter from hydrodynamic diameter for accurate nanoparticle characterization in drug delivery and material science.
Issue: Poor Reproducibility in DLS Measurements
Issue: Low Particle Count or "No Track" Errors in NTA
Issue: Discrepancy Between DLS and NTA Size Distributions
Q1: My DLS measurement shows two peaks. Which one is the real hydrodynamic diameter? A: Both may be "real" populations. The intensity-weighted distribution from DLS is biased towards larger sizes. A small population of aggregates can dominate the signal. You must analyze the volume or number distribution (if allowed by software and sample properties) to assess the primary population. Follow up with a complementary technique like NTA or SEC-DLS to separate and confirm populations.
Q2: How do I prepare serum or complex biological fluid samples for NTA? A: For plasma/serum, a 1:100 to 1:1000 dilution in filtered PBS is typically required to bring particle concentration into the optimal NTA range (10^7-10^9 particles/mL). Critical Protocol Step: Centrifuge the diluted sample at 2,000 x g for 10 minutes to remove large debris. Carefully pipette the supernatant for injection. Note that dilution may alter particle composition and measured size.
Q3: What is an acceptable PdI from DLS for considering a sample "monodisperse"? A: This is field-dependent, but general guidelines are:
Q4: How does measuring hydrodynamic diameter (Dh) help distinguish it from the core diameter? A: The difference (Dh - Core Diameter) provides critical information about the nanoparticle's surface structure. A significant difference indicates a thick coating (e.g., PEG corona, protein corona) or swelling. Protocol: Measure core diameter by TEM (dry state). Measure Dh by DLS/NTA (in solution). The "shell" or "corona" thickness can be estimated as (Dh - Core Diameter)/2.
Table 1: Key Parameter Comparison of DLS and NTA Techniques
| Parameter | Dynamic Light Scattering (DLS) | Nanoparticle Tracking Analysis (NTA) |
|---|---|---|
| Primary Measurement | Fluctuations in scattered light intensity | Brownian motion of individual particles |
| Size Range | ~0.3 nm - 10 μm | ~30 nm - 1000 nm (instrument dependent) |
| Weighting | Intensity-weighted (Z-average). Can convert to volume/number. | Number-weighted (particle-by-particle) |
| Concentration Output | Approximate, derived from correlation function | Direct measurement (particles/mL) |
| Sample Throughput | High (seconds/minutes per measurement) | Low (minutes per measurement, manual setup) |
| Key Strength | Fast, stable, ISO standard for Z-average, good for proteins. | Visual validation, mixture resolution, concentration. |
| Key Limitation | Poor resolution of mixtures, biased by large particles/aggregates. | Lower size limit, throughput, user-dependent setup. |
Table 2: Common Artifacts and Their Signatures
| Artifact | DLS Signature | NTA Signature | Corrective Action |
|---|---|---|---|
| Dust/Aggregates | Large secondary peak in intensity distribution. | Large, bright, fast-sedimenting particles. | Ultra-filtration (0.1 or 0.22 μm) of solvent/sample. |
| Air Bubbles | Erratic correlation function, huge size readings. | Large, out-of-focus circular objects. | Degas solvents, avoid vortexing before measurement. |
| Protein Corona Formation | Increase in Z-average Dh over time in biological media. | Gradual increase in mean size over time. | Pre-incubate and measure at consistent time points. |
Protocol 1: Standard Operating Procedure for DLS Hydrodynamic Diameter Measurement
Protocol 2: Standard Operating Procedure for NTA Hydrodynamic Diameter & Concentration Measurement
Title: DLS Measurement Principle & Data Flow
Title: NTA Measurement Principle & Data Flow
Title: Differentiating Core and Hydrodynamic Diameter
Table 3: Essential Materials for DLS/NTA Experiments
| Item | Function & Importance |
|---|---|
| Filtered Solvents/Buffers (0.1 μm PES filter) | Removes dust and particles that create measurement artifacts. Critical for baseline stability. |
| Disposable Cuvettes (for DLS) | Low-cost, single-use to prevent cross-contamination. Ensure they are of the correct grade (e.g., polystyrene, quartz). |
| Syringe Filters (0.02 μm Anodisc for NTA) | For final filtration of buffers directly into the NTA sample chamber to eliminate nanobubbles. |
| NIST-Traceable Size Standards (e.g., 100 nm polystyrene) | To validate instrument performance, alignment, and software settings before measuring unknown samples. |
| Disposable Syringes (1 mL for NTA) | For loading the sample into the NTA fluidic cell without introducing air bubbles. |
| Pipette Tips with Filters | Prevents aerosol contamination of samples and pipettors, crucial for concentration accuracy. |
| Non-ionic Surfactant (e.g., 0.005% Tween 20) | Can be added to buffers to minimize nanoparticle aggregation and adhesion to vial/cuvette walls. |
Q1: In my TEM images of polymeric nanoparticles for drug delivery, the measured diameter is consistently smaller than the hydrodynamic diameter from DLS. What is the cause, and how should I adjust my sample preparation?
A: This is expected and central to the thesis. TEM measures the dry, solid core (core diameter, Dc). DLS measures the hydrodynamic diameter (Dh) in suspension, which includes the core, any polymer shell, and the solvation layer. A significant discrepancy (e.g., Dh > Dc by >20 nm) suggests a thick stabilizing polymer (e.g., PEG) or significant swelling in aqueous media. For accurate Dc measurement:
Q2: My SEM images of gold nanoparticles show charging artifacts and particle aggregation. How do I obtain a clean, high-contrast image for accurate core size distribution?
A: Charging indicates inadequate conductivity. Aggregation points to poor sample preparation.
Q3: When performing automated image analysis on TEM micrographs to determine core size, how do I handle overlapping nanoparticles or irregular shapes?
A: This is a key challenge for accurate distribution statistics.
Q4: For lipid nanoparticles (LNPs) visualized by Cryo-TEM, what is the definitive feature that distinguishes the core diameter, and how is it distinguished from the bilayer?
A: In Cryo-TEM, LNPs typically show a distinct electron-dense core (containing the encapsulated drug/nucleic acid) surrounded by a less-dense, continuous lipid bilayer shell.
Table 1: Comparative Analysis of Nanoparticle Diameter Measurement Techniques
| Technique | Measures | Sample State | Output | Key Limitation for Dc vs. Dh Thesis |
|---|---|---|---|---|
| TEM | Core Diameter (Dc) | Dry, Vacuum | Number-weighted distribution, high-resolution 2D image. | May shrink/solvent evaporate; misses solvation shell. |
| Cryo-TEM | Core (& sometimes hydrated shell) | Vitrified, Hydrated | Number-weighted distribution, near-native state image. | Complex preparation; shell contrast can be low. |
| SEM | Core Diameter/ Morphology | Dry, Vacuum | 3D-like surface topology image. | Charging artifacts; less internal detail than TEM. |
| DLS | Hydrodynamic Diameter (Dh) | Liquid, Dispersed | Intensity-weighted distribution, Z-average. | Cannot resolve core; sensitive to aggregates/dust. |
Table 2: Common Discrepancies & Interpretations in Core vs. Hydrodynamic Diameter
| Dh (DLS) vs. Dc (TEM) Result | Probable Physical Interpretation | Relevance to Drug Development |
|---|---|---|
| Dh > Dc by 5-15 nm | Presence of a thin stabilizing ligand or polymer corona. | Confirms surface modification for stealth (PEGylation) or targeting. |
| Dh > Dc by >20 nm | Thick polymer shell (e.g., PEG brush) or significant particle swelling. | Indicates potential for sustained release or environmental responsiveness. |
| Dh ≈ Dc | "Naked" or very thinly coated nanoparticle. | May indicate rapid clearance or aggregation potential in biological fluids. |
| Dh < Dc | Measurement error. Likely aggregation in TEM sample or DLS fitting error. | Requires protocol re-evaluation. |
Protocol 1: TEM Sample Preparation for Core Diameter (Dc) Analysis of Metallic Nanoparticles
Protocol 2: Cryo-TEM Sample Preparation for Hydrated State Visualization
| Item | Function in Core Diameter Analysis |
|---|---|
| Carbon-coated Copper TEM Grids (200-400 mesh) | Standard substrate for sample deposition; provides a thin, electron-transparent, conductive support film. |
| Uranyl Acetate (2% aqueous solution) | Negative stain for TEM; enhances contrast of biological/polymer nanoparticles by embedding around them, defining boundaries. |
| APTES ((3-Aminopropyl)triethoxysilane) | Silane coupling agent used to functionalize silicon wafers or grids with amine groups, improving adhesion of nanoparticles. |
| Iridium Sputtering Target | Source for depositing an ultra-thin, fine-grained conductive metal coating on non-conductive samples for high-resolution SEM. |
| Liquid Ethane | Cryogen for plunge-freezing in Cryo-TEM; its high thermal conductivity enables vitrification, not crystallization, of water. |
| Quantifoil or Lacey Carbon Grids | Specialized TEM grids with holes, used for Cryo-TEM to suspend the vitrified sample over empty space for optimal imaging. |
| NIST Traceable Particle Size Standards (e.g., Au, SiO2) | Calibration standards to validate the magnification and size measurement accuracy of TEM/SEM instruments. |
Q1: My SEC column is exhibiting high backpressure. What could be the cause and how do I resolve it? A: High backpressure typically indicates column blockage. Causes include: 1) Injection of samples containing particulate matter or aggregated proteins/nanoparticles. 2) Use of a mobile phase incompatible with the column chemistry, leading to precipitation. 3) Column degradation or bed collapse over time. Resolution: Always centrifuge (e.g., 10,000-15,000 x g for 10 min) or filter (0.1 or 0.22 µm filter, compatible with sample) your samples before injection. Ensure mobile phase compatibility. For severe blockage, follow the manufacturer's column cleaning procedure. If pressure remains high, the column frit may be irreversibly clogged, requiring replacement.
Q2: I am observing poor recovery of my nanoparticle sample from the FFF channel. Where is my sample being lost? A: Sample loss in FFF can occur due to membrane adsorption or aggregation. Hydrophobic or charged nanoparticles can adhere to the accumulation wall membrane. Resolution: Optimize carrier liquid composition. Add surfactants (e.g., 0.01-0.1% SDS, Triton X-100 for non-denaturing conditions) or adjust ionic strength/pH to minimize electrostatic interactions. Use membrane materials with appropriate surface chemistry (e.g., regenerated cellulose for biologics). Perform a mass balance by quantifying sample in the channel, cross-flow, and injection loop post-run.
Q3: My SEC calibration curve seems inaccurate for my nanoparticle sample. Am I using the wrong standards? A: Yes, this is a common pitfall. SEC separates by hydrodynamic volume (Vh). Using linear polymer standards (e.g., polystyrene sulfonates) for rigid, non-spherical nanoparticles will give an erroneous size estimate. Resolution: Use calibration standards that closely match the shape and density of your analyte. For polymer-coated nanoparticles, use branched polymers or globular protein standards (e.g., thyroglobulin, ferritin). Always state the standard used when reporting sizes. Consider using online multi-angle light scattering (MALS) for absolute size determination without reliance on standards.
Q4: The retention time in my FFF run is not reproducible. What parameters should I stabilize? A: FFF retention is highly sensitive to flow dynamics and field strength. Lack of reproducibility often stems from inconsistent cross-flow control or channel condition. Resolution: 1) Ensure the cross-flow rate is stable and precisely controlled. Allow sufficient time for flow equilibration before injection. 2) Maintain constant temperature, as viscosity affects retention. 3) Regularly clean and re-condition the channel membrane to prevent fouling that alters the accumulation wall properties. 4) Use an internal retention time marker (e.g., a known, stable nanoparticle) to normalize run-to-run variations.
Q5: How do I determine if my measured diameter is a core or hydrodynamic diameter? A: This is central to your thesis. The technique dictates the measurement:
Protocol 1: Determining Hydrodynamic Diameter via SEC-MALS Objective: To obtain the absolute hydrodynamic radius (Rh) of nanoparticles without reliance on column calibration. Materials: SEC system, MALS detector, differential refractometer (dRI), appropriate SEC column (e.g., silica or polymeric matrix with suitable pore size), nanoparticle sample in suitable buffer. Procedure:
Protocol 2: Asymmetric Flow-FFF (AF4) Method Development for Polydisperse Nanoparticles Objective: To establish a fractionation method that resolves a heterogeneous mixture of nanoparticles by size. Materials: AF4 system with UV/VIS and MALS detectors, appropriate membrane (e.g., 10 kDa regenerated cellulose), carrier liquid (e.g., phosphate buffer with 0.02% sodium azide). Procedure:
Table 1: Comparative Analysis of FFF and SEC for Nanoparticle Sizing
| Feature | Size-Exclusion Chromatography (SEC) | Field-Flow Fractionation (FFF) |
|---|---|---|
| Separation Mechanism | Sieving through porous stationary phase | Laminar flow and perpendicular field (e.g., cross-flow) |
| Size Range | ~1-100 nm (pore-size dependent) | 1 nm - >100 µm (channel/method dependent) |
| Sample Interaction | Risk of adsorption to column packing | Minimal; interaction mainly with membrane |
| Resolution | High for monodisperse samples; limited by column | Very high, adjustable via field strength/decay |
| Sample Recovery | Can be low due to adsorption | Typically high (>90% with optimized method) |
| Absolute Sizing | Requires calibration standards | Can yield Dh directly from retention theory |
| Optimal Use Case | Stable, monodisperse samples in specific buffers | Polydisperse, sensitive, or large (>>50 nm) particles |
Table 2: Correlation of Diameter Measurements in Core vs. Hydrodynamic Size Studies
| Technique | Measured Diameter Type | Physical Principle | Coating/Solvation Sensitivity | Key Complementary Technique |
|---|---|---|---|---|
| TEM / SEM | Core (Dry State) | Electron scattering | No | AF4-MALS (for solution state Dh) |
| DLS | Hydrodynamic (Z-Average) | Brownian motion diffusion | High | TEM (to confirm core morphology) |
| SEC with Calibration | Apparent Hydrodynamic | Elution volume (relative to standards) | High | SEC-MALS (for absolute Dh) |
| AF4-MALS/DLS | Hydrodynamic Distribution | Retention time + light scattering | High | SAXS (for core size/shape in solution) |
| SAXS | Core (Solution State) | X-ray scattering pattern | Low | DLS (for concurrent Dh measurement) |
Table 3: Essential Materials for FFF & SEC Nanoparticle Characterization
| Item | Function | Example & Notes |
|---|---|---|
| SEC Columns | Porous stationary phase for size-based separation. | TOSOH TSKgel SW series: For aqueous biologics/nanoparticles. Agilent PLgel: For organic-soluble polymers/nanoparticles. Choose pore size matching your analyte's hydrodynamic volume. |
| AF4 Membranes | Forms the accumulation wall in FFF; critical for retention and recovery. | Regenerated Cellulose (RC): Low protein/nanoparticle adsorption, ideal for biologics. Polyethersulfone (PES): General purpose, good chemical stability. |
| Size Standards | Calibration of SEC columns; verification of FFF retention. | Protein Standards (Thyroglobulin, BSA): For aqueous SEC. Polymer Nanospheres (NIST-traceable): For absolute scale verification in FFF/DLS. |
| Mobile Phase Additives | Minimize sample-column/membrane interactions, prevent aggregation. | Surfactants (e.g., 0.02% SDS, 0.1% Tween 20): Reduce hydrophobic adsorption. Salts (e.g., 150 mM NaCl): Shield electrostatic interactions. Antimicrobials (e.g., 0.02% NaN₃): Preserve buffer for long runs. |
| Syringe Filters | Remove particulates that can clog columns/channels. | PVDF or PES membrane, 0.1 µm pore size: Compatible with most aqueous samples. PTFE membrane: For organic solvents. Always verify filter compatibility with your sample. |
| Online Detectors | Provide concentration, size, and compositional data on eluting fractions. | Multi-Angle Light Scattering (MALS): Absolute molar mass and size (Rg). Dynamic Light Scattering (DLS): Hydrodynamic radius (Rh). Differential Refractometer (dRI): Universal concentration detection. |
Q1: My SAXS data shows a high signal-to-noise ratio at low q-values. What could be the cause and how do I fix it? A: This is often due to aggregation or poor beam alignment. Ensure your nanoparticle suspension is freshly prepared and sonicated. Check for dust by visual inspection of the capillary. Realign the beam using the standard protocol: adjust the beam stop to ensure the direct beam is fully blocked and centered, and verify the sample-to-detector distance with a known standard (e.g., silver behenate).
Q2: DCS measurements yield inconsistent correlation times and poor fit quality. What are the primary troubleshooting steps? A: Inconsistent results typically stem from insufficient sample concentration or contaminants. First, verify your sample concentration is within the instrument's optimal range (typically >0.1 mg/mL for 100 nm particles). Filter all buffers and samples through a 0.02 µm syringe filter. Ensure the cuvette is perfectly clean and free of bubbles. Increase measurement duration to 3-5 minutes per run to improve statistics.
Q3: During TRPS measurement, the particle blockade rate is extremely low despite a visibly concentrated sample. Why? A: A low event rate usually indicates a pore blockage or incompatible electrolyte/surface charge. First, perform a pore "clear" function as per instrument manual. If unsuccessful, reverse the voltage polarity for 30 seconds. Ensure you are using the recommended electrolyte buffer (e.g., 0.1 M KCl with 0.05% EDTA) and that your nanoparticles carry sufficient charge (zeta potential > |20| mV). Dilute your sample in the exact same filtered electrolyte.
Q4: How do I reconcile a significant discrepancy between the core radius from SAXS and the hydrodynamic radius from DCS? A: A large discrepancy (>10% for compact, spherical particles) often indicates a thick, solvated shell or aggregation. First, confirm sample identity across techniques. Analyze SAXS data with a model that includes a shell layer (e.g., Core-Shell Sphere). In DCS, check for multiple populations in the correlation function which may suggest aggregates contributing to a larger average Rh. Cross-validate with TRPS, which provides a number-weighted size distribution of the hydrodynamic diameter in a near-native state.
Q5: My TRPS calibration with standard particles fails—the measured diameter is off by more than 10%. What should I do? A: This indicates an issue with pore stretching, electrolyte, or standard quality. Confirm the pore is properly wetted and no air bubbles are trapped. Use only fresh, filtered calibration particles from a reputable source. Ensure the temperature is stable, as viscosity changes affect calibration. Re-run the stretch calibration procedure meticulously, verifying the pore diameter in the software matches the nominal value for the nanopore membrane used.
Table 1: Comparative Analysis of Size Characterization Techniques
| Technique | Measured Property | Typical Size Range | Sample Concentration | Key Output Parameter | Typical Measurement Time |
|---|---|---|---|---|---|
| SAXS | Core & Shape | 1 - 100 nm | 1 - 10 mg/mL | Radius of Gyration (Rg), Core Radius | 1 - 30 min |
| DCS | Hydrodynamic Size | 1 nm - 1 µm | 0.01 - 1 mg/mL | Hydrodynamic Radius (Rh) | 2 - 5 min per run |
| TRPS | Hydrodynamic Size | 40 nm - 1 µm | 10^7 - 10^10 part/mL | Hydrodynamic Diameter (Dh), Concentration | 5 - 10 min |
Table 2: Interpreting Discrepancies in Core vs. Hydrodynamic Diameter
| Observation (SAXS Dcore vs. DCS Dh) | Probable Physical Interpretation | Suggested Complementary Experiment |
|---|---|---|
| Dh ≈ Dcore | Compact, non-solvated, bare particle. | TEM for direct visualization. |
| Dh > Dcore by 2-10 nm | Presence of a solvated polymer or surfactant shell. | Use SAXS Core-Shell model; measure shell contrast. |
| Dh >> Dcore (e.g., 2x) | Extensive aggregation or loose, fractal structure. | Perform TRPS for number-weighted distribution; check DCS correlation function for multi-exponential decay. |
| Data is irreproducible or fits poorly | Sample instability or impurity. | Filter samples; repeat measurement over time to monitor stability. |
Protocol 1: Integrated Workflow for Determining Core vs. Hydrodynamic Diameter
SAXS Core Size Analysis Workflow
Hydrodynamic Size Measurement Pathways
Integrating Techniques for Thesis Research
Table 3: Essential Materials for Nanoparticle Size Characterization Experiments
| Item | Function & Importance | Example Product / Specification |
|---|---|---|
| Size Calibration Standards | Essential for validating and calibrating DCS and TRPS instruments. Provides traceability. | NIST-traceable polystyrene or silica nanoparticles (e.g., 50 nm, 100 nm). |
| Anapore or NP200 Membranes | Tunable nanopores for TRPS. Different pore sizes target different particle ranges. | For 40-200 nm particles: NP150 membrane. |
| Syringe Filters (Ultra-clean) | Critical for removing dust and aggregates that cause artifacts in SAXS and DCS. | 0.02 µm Anotop or PTFE syringe filters for buffers/samples. |
| Dialysis Tubing/Membranes | For buffer exchange and purification to ensure consistent ionic strength & pH across techniques. | 10 kDa MWCO Snakeskin dialysis tubing. |
| High-Purity Salts & Buffers | Electrolyte for TRPS and dispersion medium. Impurities can clog pores or cause aggregation. | Molecular biology-grade KCl, HEPES, EDTA. |
| Quartz Capillaries or Cells | Low-scattering sample holders for SAXS measurements. | 1.5 mm diameter quartz capillaries. |
| Disposable Micro Cuvettes | For DCS measurements. Must be ultra-clean to avoid spurious scattering. | UV-transparent, low-volume (e.g., 12 µL) cuvettes. |
Q1: Why do my DLS and TEM results show significant discrepancies in nanoparticle diameter? A: Dynamic Light Scattering (DLS) measures the hydrodynamic diameter, which includes the core, coating, and solvation shell, while Transmission Electron Microscopy (TEM) visualizes the dry, core diameter. A discrepancy is expected. Large differences (>20%) may indicate aggregation, poor dispersion, or an issue with sample preparation. Ensure the DLS sample is filtered (0.22 µm syringe filter) and the TEM grid is prepared from a well-sonicated, dilute dispersion to avoid artifacts.
Q2: How can I improve the low resolution and polydispersity index (PdI) in my DLS measurements? A:
Q3: My NTA concentration is consistently lower than the theoretical or UV-Vis calculated concentration. What could be the cause? A: Nanoparticle Tracking Analysis (NTA) has a detection threshold (typically ~20-30 nm for polystyrene-equivalent size) and is sensitive to particle brightness. Smaller or dimmer particles may not be tracked. Furthermore, NTA measures the number of particles in a small sampled volume, which can lead to statistical variance. Validate your instrument settings (camera level, detection threshold) using known standard particles (e.g., 100 nm polystyrene beads). Compare with an orthogonal method like tunable resistive pulse sensing (TRPS) if available.
Q4: What is the best method to determine the "true" core size when my nanoparticle has a complex polymeric or protein corona? A: A complementary suite is essential. Use TEM or Scanning Electron Microscopy (SEM) for the dry core size. Small-Angle X-Ray Scattering (SAXS) in solution can provide the core radius of gyration (Rg) independently of the corona, as it distinguishes between different electron density regions. The workflow should be: TEM (dry core) -> SAXS (core in solution) -> DLS (hydrodynamic size) -> derive corona thickness.
Q5: How do I validate the stability of my nanoparticle formulation across different assays? A: Implement a stability checkpoint within your workflow. Measure the hydrodynamic diameter (via DLS) and zeta potential at three key points: 1) After initial synthesis/purification, 2) After preparation for each analytical technique (e.g., in TEM buffer, NTA diluent), and 3) After long-term storage (e.g., 7, 30 days). A stable formulation will show <10% change in Dh and minimal change in zeta potential.
Protocol 1: Sample Preparation for Complementary Size Analysis
Protocol 2: Multi-Technique Data Correlation Workflow
Table 1: Comparison of Key Nanoparticle Sizing Techniques
| Technique | Measured Parameter | Size Range | Weighting | Sample State | Key Output | Complementary To |
|---|---|---|---|---|---|---|
| TEM/SEM | Core Diameter | 1 nm - >1 µm | Number | Dry, Vacuum | Dcore, Morphology | DLS, SAXS |
| DLS | Hydrodynamic Diameter | 0.3 nm - 10 µm | Intensity | Solution, Native | Z-Avg Dh, PdI | TEM, NTA |
| NTA | Hydrodynamic Diameter | 10 nm - 2 µm | Number | Solution, Dilute | Conc., Dh Distribution | DLS, TEM |
| SAXS | Radius of Gyration (Rg) | 1 nm - 100 nm | Ensemble | Solution, Native | Core Rg, Shell Thickness | TEM, DLS |
| TRPS | Hydrodynamic Diameter | 40 nm - 1 µm | Number | Solution, Conductivity | Dh, Conc., Charge | NTA, DLS |
Table 2: Example Data from a Liposome Characterization Suite
| Sample ID | TEM Dcore (nm) | DLS Dh (nm) | PdI | NTA Dh (nm) | SAXS Core Rg (nm) | Calculated Shell Thickness (nm) |
|---|---|---|---|---|---|---|
| Liposome A | 85.2 ± 7.1 | 112.3 ± 1.5 | 0.08 | 109.5 ± 32.1 | 82.1 ± 0.5 | 13.6 |
| Liposome B | 102.5 ± 12.3 | 156.7 ± 3.2 | 0.21 | 148.9 ± 41.5 | 99.8 ± 1.1 | 27.1 |
Characterization Workflow for Nanoparticle Sizing
Interpreting Complementary Sizing Data
| Item | Function & Rationale |
|---|---|
| Ultrapure Water (Type I, 18.2 MΩ·cm) | Prevents interference from ions/particulates in DLS, NTA, and SAXS measurements. Essential for accurate baseline. |
| Anodisc or similar syringe filters (0.22 µm) | Removes dust and aggregates for DLS/NTA. Critical for achieving low background and reliable PdI. |
| Polystyrene or Silica Size Standards (e.g., 50 nm, 100 nm) | Used for daily calibration and validation of DLS, NTA, and TEM instruments. Ensures data accuracy. |
| Glow Discharger | Treats TEM grids to make them hydrophilic, ensuring even spreading of nanoparticle solution for representative imaging. |
| Uranyl Acetate (2%) or Phosphotungstic Acid | Negative stains for TEM, enhancing contrast of soft matter nanoparticles (liposomes, polymers) against the carbon film. |
| Diluent for NTA (Particle-Free PBS/Buffer) | Certified particle-free buffers prevent false positives in NTA particle counting and sizing. |
| Zeta Potential Transfer Standard (e.g., -50 mV) | Verifies performance of zeta potential measurements on DLS instruments, critical for stability assessment. |
Q1: My DLS measurement shows a polydispersity index (PdI) > 0.7. What does this mean and how can I improve my sample? A: A PdI > 0.7 indicates a very broad or multimodal size distribution, making the DLS intensity-weighted mean size unreliable. To improve:
Q2: Why are the peaks in my intensity distribution so different from my volume or number distribution? Which one should I report for core vs. hydrodynamic diameter research? A: Intensity weighting is sensitive to larger particles (scales with diameter to the sixth power). Small amounts of aggregates can dominate the intensity signal. Volume/number distributions are mathematically derived from the intensity data and assume spherical, homogeneous particles.
Q3: What are common DLS artifacts and how do I identify them? A: Common artifacts include:
Objective: To correlate the nanoparticle core size (from TEM) with its hydrodynamic size in solution (from DLS) and calculate the apparent surface hydration/layer thickness.
Materials & Reagents:
| Research Reagent Solution | Function in Experiment |
|---|---|
| Nanoparticle Suspension | The sample of interest (e.g., liposomes, polymeric NPs, inorganic NPs). |
| Phosphate Buffered Saline (PBS), pH 7.4 | Standard physiological dispersion medium for DLS. |
| Ultrapure, 0.1 µm Filtered Water | For diluting samples and cleaning cuvettes to remove dust. |
| Disposable Syringe Filters (0.2 µm or 0.45 µm) | For filtering nanoparticle suspensions to remove large aggregates prior to DLS. |
| Formvar/Carbon-coated TEM Grids | Substrate for depositing nanoparticles for TEM imaging. |
| Negative Stain (e.g., 1-2% Uranyl Acetate) | Enhances contrast for TEM imaging of soft nanoparticles. |
Methodology:
Data Presentation: Core vs. Hydrodynamic Diameter Analysis
| Sample ID | DLS: Z-Ave (D(_H)) (nm) | DLS: PdI | TEM: Number Mean (D(_C)) (nm) | TEM: Std Dev (nm) | Calculated Hydration Layer (δ) (nm) |
|---|---|---|---|---|---|
| Liposome A | 112.4 | 0.08 | 95.2 | 8.5 | 8.6 |
| Polymeric NP B | 65.8 | 0.15 | 50.1 | 5.2 | 7.9 |
| Gold Nanosphere | 30.2 | 0.03 | 28.5 | 2.1 | 0.9 |
FAQ 1: Why do my DLS measurements show a larger hydrodynamic diameter than expected, and how can I troubleshoot this?
FAQ 2: How does buffer selection specifically impact the core vs. hydrodynamic diameter analysis?
FAQ 3: My nanoparticle concentration is critical for my application, but DLS results are unreliable at high concentrations. What protocols can I use?
Sample: 50 nm Polystyrene Nanobeads in 1 mM NaCl buffer.
| Concentration (mg/mL) | Z-Avg Diameter (nm) | Polydispersity Index (PdI) | Interpreting the Effect |
|---|---|---|---|
| 2.0 | 78.4 ± 12.1 | 0.32 | Severe Aggregation/Multiple Scattering: Invalid data. |
| 1.0 | 62.1 ± 5.3 | 0.18 | Moderate Concentration Effect: Reversible agglomeration. |
| 0.5 | 54.8 ± 1.2 | 0.05 | Optimal Range: Size stable, low PdI. Reliable data. |
| 0.1 | 53.9 ± 0.8 | 0.04 | Optimal Range: Size stable, low PdI. Reliable data. |
| 0.05 | 53.5 ± 1.1 | 0.05 | Optimal Range: Size stable, low PdI. Reliable data. |
| Buffer/Additive | Typical Use Case | Mechanism of Action | Potential Pitfall |
|---|---|---|---|
| Phosphate Buffered Saline (PBS) | Biological nanoparticles, in vitro studies. | Physiologic pH and ionic strength. | High salt can screen charges, causing aggregation of some colloids. |
| Tris-HCl | DNA/RNA nanoparticles, protein storage. | Stable pH over a range of temperatures. | Can act as a chelating agent; may not be suitable for metal nanoparticles. |
| Citrate Buffer | Metal nanoparticles (e.g., gold, silver). | Provides electrostatic stabilization and reducing environment. | Low ionic strength; may not be compatible with cationic polymers. |
| HEPES | Cell culture experiments, sensitive proteins. | Excellent pH stability, minimal biological interference. | Can form radicals under light; not for long-term storage with some particles. |
| Polysorbate 20 (Tween 20) | Non-ionic steric stabilization. | Prevents aggregation by steric hindrance. | Can interfere with UV-vis measurements; may solubilize lipid coatings. |
| Bovine Serum Albumin (BSA) 0.1-1% | Preventing non-specific adsorption to surfaces. | Passivates surfaces and occupies binding sites. | Adds a protein corona, significantly increasing hydrodynamic diameter. |
| Item | Function in Core/Hydrodynamic Diameter Research |
|---|---|
| Zeta Potential Analyzer | Measures surface charge (zeta potential) to predict colloidal stability. A magnitude > ±30 mV typically indicates good electrostatic stability. |
| Low-Protein-Binding Filters (0.1 µm, 0.22 µm) | Removes large aggregates and dust from samples prior to DLS or NTA without adsorbing significant nanoparticle material. |
| Dynamic Light Scattering (DLS) Instrument | Measures the hydrodynamic diameter of particles in suspension based on Brownian motion. |
| Transmission Electron Microscopy (TEM) Grids | Provides a 2D image for measuring the core diameter and visualizing shape/aggregation state. Requires dry sample. |
| Nanoparticle Tracking Analysis (NTA) Instrument | Provides number-weighted size distributions and concentration, useful for polydisperse samples. Measures hydrodynamic diameter. |
| Dialysis Cassettes/Tubing | Allows for controlled buffer exchange to remove unwanted salts, surfactants, or impurities without concentrating the sample. |
| Analytical Ultracentrifuge (AUC) | Provides high-resolution, label-free size and density distributions, differentiating core from hydrodynamic size via sedimentation velocity. |
Protocol: Systematic Sample Preparation for Core vs. Hydrodynamic Diameter Comparison
Objective: To prepare a nanoparticle sample for accurate and correlative measurement of core diameter (via TEM) and hydrodynamic diameter (via DLS/NTA) while minimizing preparation artifacts.
Materials: Nanoparticle suspension, appropriate storage buffer, dilution buffer (matched), syringe filters (size-appropriate), bath sonicator, DLS cuvettes, TEM grids, tweezers.
Method:
Title: Workflow for Nanoparticle Sizing with Sample Preparation Pitfalls
Title: How Buffer Selection Leads to Size Overestimation
Q1: Our DLS measurements in serum-containing media show a much larger hydrodynamic diameter than in PBS. Is this aggregation or the protein corona? A: This is most likely the formation of a protein corona, not irreversible aggregation. To distinguish:
Q2: Why do my NTA results differ between cell culture medium and water, even for the same nominal particle concentration? A: NTA relies on light scattering and Brownian motion. Key factors differ between buffers:
Q3: When using SEC to separate coronated nanoparticles, how do I avoid column fouling and interpret the new elution volume? A: Column fouling occurs due to excess free protein or aggregated protein-particle complexes.
Q4: How can we determine the "core" diameter after corona formation for accurate corona thickness calculation? A: This is a central challenge in core vs. hydrodynamic diameter research.
Table 1: Comparative Sizing Data for 50 nm Polystyrene NPs in Different Buffers
| Characterization Technique | PBS (pH 7.4) | DMEM + 10% FBS | Apparent Size Increase | Primary Contributor |
|---|---|---|---|---|
| Dynamic Light Scattering (DLS) | 52 ± 3 nm | 68 ± 5 nm | ~16 nm | Hydrodynamic Corona |
| Nanoparticle Tracking Analysis (NTA)* | 51 ± 2 nm | 65 ± 8 nm | ~14 nm | Scattering from Corona |
| Transmission Electron Microscopy (TEM) | 49 ± 2 nm | 50 ± 2 nm (Core visible) | ~1 nm | Dense Hard Corona |
| Asymmetric Flow FFF (AF4) with MALS | 53 nm | 70 nm | ~17 nm | Hydrodynamic Radius |
*With corrected viscosity and refractive index settings.
Table 2: Troubleshooting Matrix: Expected vs. Problematic Results
| Observation | Likely Cause | Diagnostic Experiment | Solution |
|---|---|---|---|
| Size in serum >> size in PBS, high PdI | Aggregation + Corona | Re-measure in PBS; check if size returns. | Improve NP stability (e.g., better PEGylation) pre-incubation. |
| Broad, multimodal SEC peak | Heterogeneous Corona | Collect peak fractions, run SDS-PAGE. | Optimize incubation time & protein-to-NP ratio. |
| NTA concentration drops in serum | Altered scattering/background | Use fluorescent mode if possible. | Adjust detection threshold; use differential centrifugation. |
| DLS size decreases over time in serum | Corona compaction/swelling | Time-resolved DLS over 2 hours. | Report size as a time-dependent parameter. |
| Item | Function in Corona Studies |
|---|---|
| Pre-filtered Fetal Bovine Serum (FBS) | Standard, complex biological fluid model for corona formation. Must be 0.22 µm filtered to remove aggregates. |
| Phosphate Buffered Saline (PBS), pH 7.4 | Simple ionic buffer for baseline hydrodynamic diameter measurement. |
| Size Exclusion Chromatography (SEC) Columns (e.g., Superose 6 Increase) | To separate corona-coated NPs from unbound proteins and small aggregates based on hydrodynamic volume. |
| Amicon Ultra Centrifugal Filters (appropriate MWCO) | For buffer exchange, concentration of coronated NPs, and removal of excess free protein. |
| Polycarbonate Membrane Filters (0.22 µm, 0.1 µm) | For sterilizing buffers and clarifying NP suspensions post-incubation. |
| Negative Stain (1-2% Uranyl Acetate) | For TEM visualization of the protein corona's approximate boundary and morphology. |
| Certified Nanosphere Size Standards (NIST-traceable) | Essential for calibrating DLS, NTA, and SEC instruments in both simple and complex buffers. |
| Density Gradient Medium (e.g., Iodixanol) | For isolating coronated NPs via ultracentrifugation based on buoyant density. |
Objective: To isolate nanoparticles with a hard protein corona and determine their hydrodynamic diameter.
Q1: Our DLS measurements for LNPs show a polydispersity index (PDI) consistently > 0.3, indicating high heterogeneity. What are the primary experimental factors we should troubleshoot?
A: A high PDI (>0.3) suggests a non-uniform population. Key factors to investigate:
Q2: When comparing nanoparticle size from TEM (core) and DLS (hydrodynamic), our polyplexes show a >30 nm discrepancy. Is this expected, and how do we interpret it?
A: Yes, a discrepancy is expected and informative. DLS measures the hydrodynamic diameter (Dh), which includes the core, the polymer/DNA layers, and associated solvent molecules and ions. TEM typically visualizes the dehydrated core diameter (Dc) after staining.
Q3: Our LNPs show excellent size and PDI after formulation but aggregate upon freeze-thaw or during storage at 4°C. What stabilization strategies can we implement?
A: Physical instability is common. Implement these strategies:
Q4: How do we definitively determine if a measured diameter represents the core vs. the hydrodynamic size within the context of our thesis research?
A: This requires a multi-technique orthogonal approach, central to your thesis.
Protocol 1: Systematic Sizing of LNPs Using Orthogonal Techniques
Protocol 2: Optimizing Microfluidic Mixing for Low-PDI LNPs
Table 1: Comparison of Core vs. Hydrodynamic Diameter Measurement Techniques
| Technique | Principle | Measures | Sample State | Key Output | Typical Size Range | Information on Polydispersity? |
|---|---|---|---|---|---|---|
| Dynamic Light Scattering (DLS) | Brownian motion | Hydrodynamic Diameter (Dh) | Solution, native | Z-average, PDI | 0.3 nm - 10 µm | Yes, via PDI |
| Nanoparticle Tracking Analysis (NTA) | Particle scattering & motion | Hydrodynamic Diameter (Dh) | Solution, dilute | Particle concentration, size distribution | 10 nm - 2 µm | Yes, from distribution width |
| Transmission Electron Microscopy (TEM) | Electron scattering | Core Diameter (Dc) | Dry, stained | Visual image, core size | 0.5 nm - 1 µm | Qualitative, from images |
| Cryo-Electron Microscopy (Cryo-EM) | Electron scattering | Core Diameter (Dc) | Vitrified, hydrated | Visual image, core structure | 0.5 nm - 1 µm | Qualitative, from images |
| Small-Angle X-Ray Scattering (SAXS) | X-ray scattering | Core Diameter (Dc), shape | Solution | Electron density profile, core size distribution | 1 nm - 100 nm | Yes, from modeling |
Table 2: Impact of Microfluidic Parameters on LNP Formulation Properties
| Total Flow Rate (mL/min) | Flow Rate Ratio (Aq:Org) | Resultant Size (nm, DLS) | PDI | Encapsulation Efficiency (%) |
|---|---|---|---|---|
| 5 | 3:1 | 85 ± 5 | 0.12 | 92 |
| 5 | 1:1 | 65 ± 8 | 0.18 | 88 |
| 12 | 3:1 | 75 ± 3 | 0.08 | 95 |
| 12 | 1:1 | 55 ± 6 | 0.15 | 85 |
| 1 | 3:1 | 120 ± 25 | 0.35 | 75 |
Title: Workflow for Core vs Hydrodynamic Diameter Analysis
Title: Troubleshooting High Polydispersity in Nanoparticles
| Item | Function in Optimization | Example/Note |
|---|---|---|
| Microfluidic Mixer (e.g., SHM) | Enables rapid, reproducible turbulent mixing of phases for consistent nanoprecipitation, crucial for low PDI. | Staggered herringbone design provides efficient mixing at Reynolds numbers <100. |
| Precision Syringe Pumps | Delivers organic and aqueous phases at precisely controlled total flow rates (TFR) and flow rate ratios (FRR). | Key independent variables for size optimization. |
| Tangential Flow Filtration (TFF) System | Concentrates and diafiltrates formulated nanoparticles into the final storage buffer, removing organic solvent and unencapsulated material. | Essential for purification and buffer exchange at preparative scale. |
| Dynamic Light Scattering (DLS) Instrument | Provides primary characterization of hydrodynamic diameter (Dh) and polydispersity index (PDI) in solution. | Always filter buffers (0.22 µm) and use appropriate dilution for accurate measurement. |
| Cryo-EM Grids & Vitrobot | Prepares vitrified, hydrated samples for visualization of nanoparticle core structure and measurement of core diameter (Dc). | Preserves native state without staining artifacts. |
| Stable Lipid Stocks | High-purity, chromatographically verified ionizable lipids, phospholipids, cholesterol, and PEG-lipids. | Store in chloroform or ethanol under inert gas (Argon) at -80°C to prevent oxidation. |
| Cryoprotectants (Sucrose/Trehalose) | Added pre-freeze to form an amorphous glassy matrix, protecting LNPs from fusion during freeze-thaw cycles. | Typically used at 5-10% (w/v) final concentration. |
Q1: My DLS measurement shows a hydrodynamic diameter significantly larger than the TEM core diameter. What are the primary causes? A: A consistently larger hydrodynamic diameter (by >20%) indicates a substantial surface coating or aggregation. Key causes are:
Q2: My core size (from TEM) is larger than my hydrodynamic size (from DLS). This seems physically impossible. What's wrong? A: This is a critical red flag suggesting a fundamental measurement or interpretation error.
Q3: How can I systematically diagnose the cause of a core vs. hydrodynamic size discrepancy? A: Follow this experimental diagnostic workflow:
Step 1: Validate DLS Data. Ensure a high-quality correlation function, run the sample at multiple concentrations to rule out concentration-dependent aggregation, and verify solvent parameters. Step 2: Validate TEM/SEM Sampling. Count and measure a statistically significant number of particles (>500) from multiple grid squares. Perform ImageJ analysis to get a number-weighted distribution. Step 3: Introduce a Separation Step. Use asymmetric flow field-flow fractionation (AF4) or size exclusion chromatography (SEC) online with DLS/MALS to separate populations by hydrodynamic size before measurement. Step 4: Probe Surface State. Use techniques sensitive to the hydrodynamic layer: compare DLS in good vs. theta-solvent for polymers, or use microelectrophoresis (zeta potential) to infer coating thickness via the shift in shear plane.
Q4: For lipid nanoparticles (LNPs), the core-shell model often fails. How should I interpret the data? A: LNPs are soft, dynamic structures. A larger hydrodynamic size than the electron microscopy "core" is expected due to the hydrated lipid bilayer, PEG corona, and possible adsorbed proteins. Use the discrepancy quantitatively: the difference (Dh - Dcore) / 2 gives an estimate of the effective hydrodynamic shell thickness in your specific buffer.
Table 1: Expected vs. Problematic Size Discrepancies
| Scenario | Core Diameter (TEM) | Hydrodynamic Diameter (DLS) | Discrepancy (Dh - Dcore) | Likely Interpretation |
|---|---|---|---|---|
| Expected Coating | 50 nm | 65 nm | +15 nm | Consistent with a ~7.5 nm thick stabilizing polymer or protein corona. |
| Red Flag: Aggregation | 50 nm | 120 nm (PdI > 0.3) | +70 nm | Suspension contains dimers/trimers or larger aggregates. |
| Red Flag: Measurement Error | 80 nm | 60 nm | -20 nm | TEM sampling bias (measured only large aggregates) or incorrect DLS analysis parameters. |
| Soft/Spherical Polymer | 100 nm | 140 nm (in good solvent) | +40 nm | Significant swelling of polymer network by solvent. |
Table 2: Diagnostic Techniques & Their Information
| Technique | Measures | Key Output for Discrepancy Diagnosis |
|---|---|---|
| Dynamic Light Scattering (DLS) | Hydrodynamic Diameter (Dh) | Intensity-weighted size distribution, Polydispersity Index (PdI), Correlation function quality. |
| Transmission Electron Microscopy (TEM) | Core/ Dry Diameter (Dcore) | Number-weighted size distribution, morphology, aggregation state in dry form. |
| Asymmetric Flow Field-Flow Fractionation (AF4) | Hydrodynamic Size Separation | Fractionates by Dh prior to detection (e.g., by DLS or MALS), resolves sub-populations. |
| Multi-Angle Light Scattering (MALS) | Radius of Gyration (Rg) | Rg/Rh ratio indicates particle conformation (e.g., solid sphere vs. random coil). |
Protocol 1: Cross-Validated Size Measurement for Hard Nanoparticles
Protocol 2: AF4-DLS-MALS for Resolving Heterogeneous Populations
Diagnostic Workflow for Size Discrepancies
Multi-Method Nanoparticle Sizing Strategy
| Item | Function & Importance |
|---|---|
| Size Exclusion Chromatography (SEC) Columns | For gentle, size-based separation of nanoparticles from unbound ligands or small aggregates prior to analysis. |
| AF4 Membranes (Regenerated Cellulose, Polyethersulfone) | The semi-permeable membrane in AF4 channels that enables field-flow separation; choice of MWCO is critical. |
| Negative Stains (Uranyl Acetate, Phosphotungstic Acid) | Heavy metal salts for TEM that provide contrast by embedding around nanoparticles, outlining structure. |
| Certified Nanosphere Size Standards (NIST-traceable) | Essential for calibrating DLS, TEM, and AF4 systems to ensure measurement accuracy. |
| Sterile, Low-Binding Filters (PES, 0.22 µm) | For removing dust and large aggregates from nano-suspensions without significant sample loss prior to DLS. |
| Theta-Solvent for Polymer-Coated NPs | A solvent where the polymer coating is in a near-unperturbed state, allowing estimation of its dry thickness via DLS. |
Q1: My DLS-measured hydrodynamic diameter in serum-containing media is significantly larger than the core diameter from TEM. Is this nanoparticle aggregation or protein corona formation?
A: This is a common observation and likely indicates protein corona formation, not necessarily aggregation. To diagnose:
Q2: My nanoparticles show excellent colloidal stability (consistent DLS size) in PBS, but rapidly aggregate in biologically relevant media (e.g., DMEM). How can I troubleshoot formulation stability?
A: This highlights the gap between simple buffer and complex in vitro media. Follow this protocol:
Q3: How do I correlate a specific in vitro size measurement (e.g., DLS in full serum) with in vivo pharmacokinetics data like circulation half-life?
A: The correlation is not 1:1 but is based on thresholds and trends. Use this framework:
| In Vitro Size Measurement (DLS in 100% FBS, 37°C) | Observed In Vivo Performance Trend | Probable Mechanism |
|---|---|---|
| Size remains < 100 nm, PDI < 0.2 | Long circulation half-life (>6 hrs in mice) | Effective evasion of RES/MPS uptake due to minimal aggregation and "stealth" corona. |
| Size increases to 150-300 nm, moderate PDI (0.2-0.3) | Short circulation half-life (<1 hr) | Opsonization and rapid clearance by liver and spleen macrophages. |
| Size > 500 nm or visible precipitate | Very rapid clearance, potential lung accumulation | Significant aggregation leading to mechanical filtration in capillary beds. |
Protocol: To generate this data, incubate your NP formulation in 100% FBS at 37°C with gentle rotation for 1 hour. Filter through a 0.45 µm syringe filter to remove any large aggregates. Perform DLS measurements in triplicate at 37°C. Use this "biological fluid-adjusted" size as a key predictor.
Q4: What is the most reliable method to determine the "true" core diameter for irregularly shaped nanoparticles when TEM seems unreliable?
A: Use a multi-technique approach to triangulate the core size.
| Item | Function & Relevance to Size-PERFORMANCE Correlation |
|---|---|
| Zeta Potential Cell | Measures surface charge (zeta potential) in different media. A shift towards neutral charge in serum indicates protein corona formation, predicting opsonization. |
| Dynamic Light Scattering (DLS) Instrument with Titrator | Allows automated measurement of hydrodynamic size as a function of pH or ionic strength, crucial for testing stability in physiological gradients. |
| Size Exclusion Chromatography (SEC) Columns | Separates nanoparticles from free proteins/unbound molecules. Used to isolate the protein corona for analysis or to obtain a monodisperse fraction for in vivo injection. |
| Density Gradient Media (e.g., Sucrose, Iodixanol) | Used in ultracentrifugation to isolate nanoparticles with specific densities (e.g., with/without corona) for downstream size analysis or functional testing. |
| Quasi-Elastic Light Scattering (QELS) Capillary Cell | Enables DLS measurement in small volume (< 3 µL) or precious samples, such as nanoparticle fractions collected from SEC or animal serum post-injection. |
| Reference Nanosphere Standards (NIST-traceable) | Essential for calibrating and validating TEM, DLS, and NTA instruments to ensure accuracy across core and hydrodynamic measurements. |
Diagram Title: Workflow for Core vs Hydrodynamic Size Analysis and In Vivo Correlation
Diagram Title: Protein Corona Formation Drives Hydrodynamic Size and In Vivo Fate
Q1: My nanoparticles show minimal tumor accumulation despite being within the reported "EPR window" (e.g., 50-150 nm). What could be the issue? A: The most common issue is a discrepancy between core diameter and hydrodynamic diameter. The EPR effect is governed by the hydrodynamic diameter (Dh), which includes the core, coating, and hydration shell. If your Dh is larger than measured due to aggregation or thick polymer clouds, particles may be trapped by the spleen or liver sinusoids. Verify Dh using dynamic light scattering (DLS) in relevant biological media (e.g., PBS with 10% FBS) and compare to core size from TEM.
Q2: During in vivo studies, my nanoparticles clear from circulation too quickly. How can I adjust size parameters to prolong half-life? A: Rapid clearance often indicates:
Q3: How do I accurately determine the core diameter versus the hydrodynamic diameter for my metal-organic framework (MOF) nanoparticles? A: This requires a multi-technique approach:
Q4: My nanoparticle formulation has a low PDI by DLS, but TEM shows a broad size distribution. Which result should I trust? A: Trust the TEM for core size distribution. DLS is highly sensitive to larger particles/aggregates (intensity scales with diameter to the sixth power). A few large aggregates can mask a polydisperse population of small particles, giving a falsely low PDI. Always use TEM/SEM for number-weighted core size distribution and DLS for in-situ hydrodynamic behavior.
Issue: Inconsistent Targeting Outcomes Linked to Size Measurements
| Symptom | Possible Root Cause | Diagnostic Experiment | Corrective Action |
|---|---|---|---|
| Low tumor uptake, high liver/spleen uptake. | Hydrodynamic Diameter (Dh) > 150 nm. | Perform DLS in serum-containing buffer at 37°C. | Improve formulation homogeneity; reduce polymer molecular weight or coating density. |
| Rapid renal clearance, whole-body distribution. | Dh < 10 nm; core size may be <6 nm. | Perform TEM for core size; use AF4-DLS for accurate small-particle Dh. | Increase core size or coating thickness to elevate Dh to >15 nm. |
| Good initial uptake, but rapid tumor clearance. | Nanoparticle aggregation in tumor interstitium due to unstable Dh. | Incubate nanoparticles in tumor homogenate, then measure Dh. | Optimize surface chemistry for stability in acidic, protein-rich environments. |
Issue: Discrepancies Between Different Size Measurement Techniques
| Technique | Measures | Common Artifact | How to Cross-Validate |
|---|---|---|---|
| TEM/SEM | Core diameter (dry state). | Sampling bias, drying artifacts. | Use >200 particles. Correlate with XRD-derived crystallite size. |
| DLS | Hydrodynamic diameter (solution). | Dominance by aggregates, dust. | Filter samples (0.22 µm); always report PDI. Use cumulants analysis. |
| NTA (Nanoparticle Tracking) | Particle concentration & Dh distribution. | Misses particles outside camera sensitivity. | Use alongside DLS; validate with known size standards. |
| AF4-MALS-DLS | True, separated Dh distribution. | Method development complexity. | Use to validate batch-mode DLS results for complex formulations. |
Table 1: Nanoparticle Size Parameters and In Vivo Fate
| Hydrodynamic Diameter (Dh) Range | Primary Clearance Mechanism | Expected Blood Half-Life | Primary Tumor Targeting Route |
|---|---|---|---|
| < 6 nm (Core < 3 nm) | Rapid renal excretion | Minutes | Passive diffusion, not EPR |
| 10 - 30 nm | Renal (partial), Hepatic | 1 - 4 hours | EPR (deep penetration) |
| 50 - 150 nm | Mononuclear Phagocyte System (MPS) | 6 - 24 hours (with stealth) | Optimal EPR (balance of accumulation/penetration) |
| 150 - 300 nm | Splenic filtration, MPS | < 2 hours | EPR (limited to leaky vasculature) |
| > 300 nm | Lung capillary bed, MPS | Minutes | Macrophage uptake, marginal EPR |
Table 2: Key Techniques for Core vs. Hydrodynamic Diameter Determination
| Technique | Measured Parameter | Typical Size Range | Key Output for Thesis Research |
|---|---|---|---|
| Transmission Electron Microscopy (TEM) | Core Diameter (Number-Weighted) | 1 - 500 nm | D_core (average), σ (standard deviation) |
| Dynamic Light Scattering (DLS) | Hydrodynamic Diameter (Intensity-Weighted) | 1 nm - 10 µm | D_h (Z-Avg.), Polydispersity Index (PDI) |
| Asymmetric Flow FFF (AF4) + MALS/DLS | Hydrodynamic Diameter (Separated by Size) | 1 nm - 1 µm | D_h distribution free of aggregation artifacts |
| Small-Angle X-Ray Scattering (SAXS) | Core Diameter (Ensemble, in solution) | 1 - 100 nm | D_core, shape, and shell thickness info |
Protocol 1: Correlating Core (TEM) and Hydrodynamic (DLS) Diameters Objective: To accurately measure and compare the core diameter (Dcore) and hydrodynamic diameter (Dh) of synthesized polymeric nanoparticles. Materials: Nanoparticle suspension, TEM grid (carbon-coated), filter (0.22 µm), DLS instrument, phosphate-buffered saline (PBS). Procedure:
D_core and D_h data. The difference (D_h - D_core) indicates the effective thickness of the coating/solvation layer, critical for predicting in vivo behavior.Protocol 2: Assessing Size Stability and Protein Corona Formation in Serum Objective: To determine how the hydrodynamic diameter changes in biological media, simulating in vivo conditions. Materials: Nanoparticle suspension, fetal bovine serum (FBS), PBS, DLS instrument, 37°C incubator. Procedure:
D_h and PDI at time = 0 (Protocol 1, steps 3-4).D_h and PDI at key time points (e.g., 0.5, 1, 2, 4, 24 hours).D_h versus time. A significant increase (>20%) indicates aggregation or protein corona formation.
Thesis Context Analysis: This experiment yields the "biological D_h," which is the true predictor of EPR and clearance, linking synthetic parameters to functional performance.| Item | Function in Size/Performance Research |
|---|---|
| Poly(ethylene glycol) (PEG) Thiols (e.g., mPEG-SH) | Forms a dense, hydrophilic brush on gold or semiconductor nanoparticle cores to control D_h, reduce opsonization, and prolong circulation. |
| DSPE-PEG (Lipid-PEG Conjugate) | A standard for creating stealth lipid nanoparticles (LNPs) and liposomes; inserts into lipid bilayers to provide a steric barrier, modulating D_h. |
| Phosphate Buffered Saline (PBS), 10% FBS | Standard medium for simulating physiological conditions in DLS measurements to assess colloidal stability and protein corona formation. |
| Size Standard Nanospheres (e.g., 50nm, 100nm Polystyrene) | Essential for calibrating and validating DLS, NTA, and TEM measurements. Provide a benchmark for accuracy. |
| 0.22 µm Syringe Filters (PES membrane) | For removing dust and large aggregates from nanoparticle suspensions prior to DLS or injection, ensuring measurement accuracy. |
| Uranyl Acetate (1% aqueous) | Negative stain for TEM; enhances contrast of polymeric or lipid-based nanoparticles for precise D_core measurement. |
Title: How Core and Hydrodynamic Size Determine Biological Fate
Title: Research Workflow for Core vs. Hydrodynamic Diameter Thesis
FAQ: Measurement Discrepancies & Data Interpretation
Q1: Why do I get different size values from DLS (Dynamic Light Scattering) versus TEM (Transmission Electron Microscopy)? How do I know which one represents the "true" core diameter? A: DLS measures the hydrodynamic diameter (Dh), which includes the core, coating, and solvation shell in solution. TEM measures the core diameter (Dc) of dried particles. The difference (Dh - Dc) is critical and indicates the thickness of the surface coating and hydration layer. If your nanoparticle is intended for intravenous delivery, Dh is more relevant for predicting in vivo behavior. A large discrepancy may indicate aggregation or an unexpectedly thick coating.
Q2: My DLS data shows a high PDI (Polydispersity Index). What are the main experimental causes and how can I improve measurement? A: A high PDI (>0.2) suggests a non-uniform sample. Common causes and solutions:
Q3: When benchmarking against a clinical candidate (e.g., Doxil), what are the most critical physicochemical parameters to compare beyond size? A: A comprehensive comparative analysis must include, at a minimum, the parameters in Table 1. Size influences EPR (Enhanced Permeability and Retention) effect and clearance, while surface charge (zeta potential) impacts stability and cellular interaction. Drug loading and release kinetics are direct indicators of therapeutic performance.
Table 1: Key Physicochemical Parameters for Benchmarking
| Parameter | Clinical Candidate (e.g., Doxil) | Your Nanoparticle | Measurement Technique | Significance for Benchmarks |
|---|---|---|---|---|
| Hydrodynamic Diameter (Dh) | ~80-90 nm | [Your Value] nm | DLS, NTA | Blood circulation, tumor accumulation via EPR. |
| Core Diameter (Dc) | ~50-60 nm | [Your Value] nm | TEM, SEM | Core material volume, drug loading capacity. |
| Polydispersity Index (PDI) | <0.1 | [Your PDI] | DLS | Batch uniformity and reproducibility. |
| Zeta Potential | ~ -30 to -40 mV (in water) | [Your Value] mV | Electrophoretic Light Scattering | Colloidal stability (≥ ±30 mV for electrostatic stability). |
| Drug Loading (wt%) | ~8-10% (doxorubicin) | [Your Value] % | HPLC/UV-Vis after rupture | Therapeutic payload efficiency. |
| Release Kinetics (t50%) | Slow (days, pH-independent) | [Your Value] hours/days | Dialysis at pH 7.4 & 5.5 | Drug release profile at target site vs in circulation. |
Q4: What is a detailed protocol for determining both Dc and Dh on the same nanoparticle batch? A: Integrated Core & Hydrodynamic Diameter Protocol
Sample Preparation:
TEM for Core Diameter (Dc):
DLS for Hydrodynamic Diameter (Dh):
Q5: How can I diagram the logical decision process for nanoparticle characterization? A: The following workflow guides the characterization strategy.
Decision Workflow for Nanoparticle Characterization
Table 2: Essential Materials for Nanoparticle Benchmarking Experiments
| Item | Function & Rationale |
|---|---|
| Nanoparticle Standards (e.g., NIST-traceable polystyrene beads) | Essential for calibrating DLS and NTA instruments. Provides accuracy for hydrodynamic diameter measurements. |
| Disposable Zeta Cells & Cuvettes | Prevents cross-contamination between samples, which is critical for sensitive zeta potential and DLS measurements. |
| 0.22 µm Syringe Filters (PES or PVDF membrane) | For clarifying nanoparticle dispersions immediately before DLS/NTA to remove dust and large aggregates. |
| Dialysis Membranes (e.g., 10-100 kDa MWCO) | For performing drug release kinetics studies under sink conditions, mimicking physiological diffusion. |
| Carbon-Coated TEM Grids | Standard substrate for high-resolution imaging of nanoparticle core morphology and size. |
| Ammonium Acetate Buffer (Volatile) | Ideal buffer for preparing TEM samples as it leaves minimal salt crystal artifacts upon drying. |
| Stable Reference Nanoparticle (e.g., bare gold nanospheres) | An in-lab control for routine instrument performance checks (TEM size, DLS, UV-Vis absorbance). |
| Size-Exclusion Chromatography (SEC) Columns | For high-resolution separation and purification of nanoparticles by hydrodynamic size, reducing PDI. |
Q1: Our DLS measurements for hydrodynamic diameter show high polydispersity (%Pd) despite a monomodal size distribution from TEM. What could cause this discrepancy? A: This is a classic sign of nanoparticle aggregation or swelling in the dispersion medium used for DLS. TEM measures the dry, core diameter in a vacuum, while DLS measures the hydrodynamic diameter (core + stabilizer/solvent layer) in solution. High %Pd in DLS suggests a non-uniform population in solution. First, verify that the dispersion buffer (e.g., PBS) matches your formulation's intended dispersion medium. Filter buffers through a 0.2 µm filter. Sonication of the sample prior to measurement is often essential to break up transient aggregates. Ensure the sample concentration is within the instrument's optimal range.
Q2: How do we set justified specification tolerances for core diameter from TEM and hydrodynamic diameter from DLS in a CMC filing? A: Tolerances must be based on your process capability and linked to critical quality attributes (CQAs). Analyze at least 3-5 independent batches manufactured at pilot scale. For TEM core diameter, calculate the mean ± 3 standard deviations (SD) from particle counts (>200 particles per batch). For DLS hydrodynamic diameter (Z-Average), use the mean ± 3SD of the intensity-weighted distribution from multiple runs. The acceptance criteria must be tighter than the process capability to ensure control. For example, if your process yields a hydrodynamic diameter of 100 nm ± 10 nm (3SD), your specification might be set at 100 nm ± 15 nm.
Q3: What is the recommended protocol to correlate core and hydrodynamic diameter measurements for a single batch? A: A direct correlation requires careful sample handling.
Protocol 1: Dynamic Light Scattering (DLS) for Hydrodynamic Diameter
Protocol 2: Transmission Electron Microscopy (TEM) for Core Diameter
Table 1: Representative Specification Setting for a PEGylated Liposome
| Batch No. | TEM Core Diameter (nm) Mean ± SD | DLS Hydro. Diameter (nm) Z-Avg ± SD | DLS PdI |
|---|---|---|---|
| B001 | 75.2 ± 3.1 | 98.5 ± 1.8 | 0.08 |
| B002 | 76.8 ± 3.4 | 101.2 ± 2.1 | 0.09 |
| B003 | 74.9 ± 3.8 | 99.8 ± 1.9 | 0.07 |
| Process Mean ± 3SD | 75.6 ± 10.5 | 99.8 ± 5.7 | - |
| Proposed Spec | 75 ± 15 nm | 100 ± 10 nm | ≤ 0.10 |
Table 2: Key Research Reagent Solutions
| Reagent/Material | Function |
|---|---|
| HEPES Buffered Saline | A common, well-defined dispersion medium for DLS that avoids interference from phosphate aggregates. |
| 0.2 µm Syringe Filter | Essential for removing dust and particulate contaminants from all buffers prior to DLS measurements. |
| 2% Uranyl Acetate | Common negative stain for TEM; enhances contrast by embedding particles in an electron-dense background. |
| Carbon-Coated TEM Grids | Provide a stable, conductive support film for high-resolution TEM imaging of nanoparticles. |
| Size Standard Reference (e.g., 100 nm polystyrene beads) | Used for daily calibration and validation of both DLS and TEM instruments. |
Title: Core vs Hydrodynamic Diameter Measurement Workflow
Title: Logic for Setting Size Tolerances in CMC
This support center addresses common issues in experiments focused on determining core vs. hydrodynamic nanoparticle diameter using AI/ML and high-throughput methods.
Q1: Our Dynamic Light Scattering (DLS) data shows a high polydispersity index (PDI > 0.2), which confounds the hydrodynamic size analysis for model training. What are the primary causes and solutions? A1: High PDI often indicates a non-monodisperse sample or measurement artifacts.
Q2: When using TEM/SEM for core size measurement, the size distribution from our automated image analysis script deviates significantly from manual counting. How can we improve accuracy? A2: This is typically a preprocessing or model training data issue.
Q3: Our machine learning model, trained on synthetic data, performs poorly when predicting core size from real-world TEM images. How do we bridge this simulation-to-reality gap? A3: This is a domain adaptation problem.
Q4: In a high-throughput screening (HTS) workflow, how do we reconcile discrepancies between size data from orthogonal techniques (e.g., NTA vs. DLS)? A4: Discrepancies arise from each technique's weighting and sensitivity.
Table 1: Recommended Sample Concentrations for Hydrodynamic Size Analysis
| Technique | Typical Conc. Range | Key Parameter Monitored | Optimal Signal Threshold |
|---|---|---|---|
| Dynamic Light Scattering (DLS) | 0.1 - 1 mg/mL (poly.) | Scattering Intensity | 200 - 500 kcps |
| Nanoparticle Tracking Analysis (NTA) | 10^7 - 10^9 particles/mL | Tracks/Frame | 20 - 100 tracks/frame |
| Tunable Resistive Pulse Sensing (TRPS) | 5x10^8 - 5x10^9 particles/mL | Blockade Rate | 100 - 500 particles/min |
Table 2: Characteristic Outputs from Primary Size Characterization Techniques
| Technique | Measured Diameter Type | Weighting | Key Output Metric | Typical Precision (for mono. samples) |
|---|---|---|---|---|
| TEM/SEM | Core Diameter | Number | Mean ± SD (from counting) | ± 0.5 - 2 nm |
| DLS | Hydrodynamic (Z-Avg) | Intensity | Z-Average, PDI | ± 1-3% of Z-Avg |
| NTA | Hydrodynamic (per-particle) | Number | Mode, Mean, D10, D50, D90 | ± 5-10% of Mode |
Protocol 1: Correlative Sizing for AI Model Training Data Generation Objective: Generate a paired dataset of core (TEM) and hydrodynamic (DLS/NTA) diameters for the same nanoparticle batch.
Protocol 2: High-Throughput Sizing Workflow Using Microfluidics and In-line DLS Objective: Automate size measurement for screening formulation parameters.
Diagram 1: AI for Size Correlation Workflow
Diagram 2: DLS High PDI Troubleshooting
| Item | Function & Relevance to Core/Hydrodynamic Sizing |
|---|---|
| Size Exclusion Chromatography (SEC) Columns | Pre-fractionates nanoparticles by hydrodynamic size prior to DLS/TEM, reducing PDI and improving measurement clarity for model training data. |
| Certified Nanosphere Size Standards (NIST-traceable) | Essential for daily calibration of DLS, NTA, and TRPS instruments to ensure hydrodynamic size data accuracy. |
| Carbon-Coated TEM Grids (200 mesh) | Provides a clean, conductive background for high-contrast imaging of nanoparticle core structure. |
| 0.22 µm Syringe Filters (PES membrane) | Removes dust and large aggregates from samples before any hydrodynamic size measurement, critical for reliable data. |
| Negative Stain (2% Uranyl Acetate) | Enhances contrast of organic nanoparticles (e.g., polymeric/lipid NPs) in TEM, allowing clear visualization of the core boundary. |
| Stable Reference Material (e.g., Au NPs, 30 nm) | Used as an internal control in correlative studies to verify both TEM sizing (core) and DLS sizing (hydrodynamic) on the same platform. |
| Microfluidic Mixers (Staggered Herringbone) | Enables reproducible, high-throughput synthesis of nanoparticle libraries with graded properties for generating large AI training datasets. |
Accurately determining and distinguishing between core and hydrodynamic diameter is not merely a technical checkbox but a fundamental prerequisite for rational nanomedicine design. Mastering foundational concepts, selecting complementary methodologies, rigorously troubleshooting data, and validating size parameters against biological outcomes form an essential feedback loop. As the field advances towards more complex targeted and multifunctional nanoparticles, integrating robust, multi-technique size analysis with predictive modeling will be critical for accelerating the translation of nanotherapeutics from bench to clinic, ensuring reproducible efficacy and safety.